Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Aerts

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
European Journal of Medical Genetics|December 5, 2022
Retinoblastoma: From genes to patient careY Bouchoucha, A Matet, A Berger, et al.
Hepatology International|September 10, 2021
Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategiesM Illiano, M Colinard, S Taque, et al.
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.
Pediatric Blood & Cancer|February 13, 2019
Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelinesYvan de la Monneraye, J Michon, H Pacquement, et al.
ESMO Open|September 25, 2021
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)<sup>☆</sup>N Gaspar, Q Campbell-Hewson, S Gallego Melcon, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
European Journal of Medical Genetics|December 5, 2022
Retinoblastoma: From genes to patient careY Bouchoucha, A Matet, A Berger, et al.
Hepatology International|September 10, 2021
Long-term morbidity and mortality in 2-year hepatoblastoma survivors treated with SIOPEL risk-adapted strategiesM Illiano, M Colinard, S Taque, et al.
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.
Pediatric Blood & Cancer|February 13, 2019
Indications and results of diagnostic biopsy in pediatric renal tumors: A retrospective analysis of 317 patients with critical review of SIOP guidelinesYvan de la Monneraye, J Michon, H Pacquement, et al.
ESMO Open|September 25, 2021
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)<sup>☆</sup>N Gaspar, Q Campbell-Hewson, S Gallego Melcon, et al.
Pageof 2